Since adipokines derived from omental adipose tissue are clearly involved in insulin resistance, dyslipidemia and coronary artery disease [1,19-21], new adipokines such as omentin might play an important role in the pathogenesis of T2D and associated metabolic disorders. The gene discussed is ITLN1; the disease is metabolic disease.